ALNOV:EPA
Novacyt SA
€ ०.४४
०.००%
(०.००) 1D
नोभेम्बर १९, १७:३५:१९ GMT+१ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALNOV...
Open
€ ०.४४
High
€ ०.४५
Low
€ ०.४४
Mkt. cap
३.१९ करोड
Avg. vol.
१.३७ लाख
Volume
९४.८७ हजार
52-wk high
€ १.०४
52-wk low
€ ०.२९
EPS
-€ ०.३८
Shares outstanding
७.२६ करोड
No. of employees
२२८
Open
€ ०.४४
High
€ ०.४५
Low
€ ०.४४
Mkt. cap
३.१९ करोड
Avg. vol.
१.३७ लाख
Volume
९४.८७ हजार
52-wk high
€ १.०४
52-wk low
€ ०.२९
EPS
-€ ०.३८
Shares outstanding
७.२६ करोड
No. of employees
२२८
News stories
From web sources and news partners
ChartMill
·
३७ मिनेट पहिले
Most-Active S&P 500 Stocks: Ford, Super Micro, Pfizer Lead Session Volume
TradingView
·
२ घण्टा पहिले
Anthropic Jumps 27% in Record Debut, S&P 500 Eyes Sixth Straight Loss: Stock Market Today
The Motley Fool
·
५८ मिनेट पहिले
The S&P 500 Is Flashing Warning Signs. Here's Why Long-Term Investors Should Stay the Course.
Traders Union
·
२२ मिनेट पहिले
Sam Ro: Nvidia nears 25th anniversary of S&P 500 inclusion
Profile
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
About Novacyt SA
CEODavid Allmond
Employees२२८
Founded२००६ जुलाई ३
Headquarters-
SectorHealth Care
Industry-
Websitenovacyt.com